Function of NOD-like receptors in immunity and disease

Current Opinion in Investigational Drugs

Volumn 11, Issue 11, 2010, Pages 1246-1255

  Dagenais, Maryse ^a   Dupaul Chicoine, Jeremy ^a   Saleh, Maya ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

Caspase; infection; inflammasome; inflammation; inflammatory disease; innate immunity; MAPK; NF B; NOD like receptor; therapeutic strategy

Indexed keywords

CYTOSOL RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERLEUKIN 1BETA CONVERTING ENZYME; MITOGEN ACTIVATED PROTEIN KINASE; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR;

ADAPTIVE IMMUNITY; CELL INVASION; CELL STRESS; CELLULAR DISTRIBUTION; EFFECTOR CELL; HUMAN; INFLAMMATION; INNATE IMMUNITY; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TISSUE INJURY; TISSUE REPAIR;

EID: 78650340744     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Inohara N, Koseki T, del Peso L, Hu Y, Yee C, Chen S, Carrio R, Merino J, Liu D, Ni J, Nunez G: NOD1, an APAF-1-like activator of caspase-9 and nuclear factor-κB. J Biol Chem (1999) 274(21):14560-14567.
2. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP et al: A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature (2001) 411(6837):603-606.
3. Ting JP, Lovering RC, Alnemri ES, Bertin J, Boss JM, Davis BK, Flavell RA, Girardin SE, Godzik A, Harton JA, Hoffman HM et al: The NLR gene family: A standard nomenclature. Immunity (2008) 28(3):285-287.
4. Neerincx A, Lautz K, Menning M, Kremmer E, Zigrino P, Hösel M, Büning H, Schwarzenbacher R, Kufer TA: A role for the human nucleotide-binding domain, leucine-rich repeatcontaining family member NLRC5 in antiviral responses. J Biol Chem (2010) 285(34):26223-26232.
5. Dupaul-Chicoine J, Yeretssian G, Doiron K, Bergstrom KS, McIntire CR, LeBlanc PM, Meunier C, Turbide C, Gros P, Beauchemin N, Vallance BA et al: Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity (2010) 32(3):367-378.
6. Keller M, Ruegg A, Werner S, Beer HD: Active caspase-1 is a regulator of unconventional protein secretion. Cell (2008) 132(5):818-831.
7. de Rivero Vaccari JP, Lotocki G, Marcillo AE, Dietrich WD, Keane RW: A molecular platform in neurons regulates inflammation after spinal cord injury. J Neurosci (2008) 28(13):3404-3414.
8. Kummer JA, Broekhuizen R, Everett H, Agostini L, Kuijk L, Martinon F, van Bruggen R, Tschopp J: Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a sitespecific role in the inflammatory response. J Histochem Cytochem (2007) 55(5):443-452.
9. Yin Y, Yan Y, Jiang X, Mai J, Chen NC, Wang H, Yang XF: Inflammasomes are differentially expressed in cardiovascular and other tissues. Int J Immunopathol Pharmacol (2009) 22(2): 311-322.
10. Benko S, Magalhaes JG, Philpott DJ, Girardin SE: NLRC5 limits the activation of inflammatory pathways. J Immunol (2010) 185(3):1681-1691.
11. LeibundGut-Landmann S, Waldburger JM, Krawczyk M, Otten LA, Suter T, Fontana A, Acha-Orbea H, Reith W: Mini-review: Specificity and expression of ciita, the master regulator of MHC class II genes. Eur J Immunol (2004) 34(6):1513-1525.
12. Barnich N, Aguirre JE, Reinecker HC, Xavier R, Podolsky DK: Membrane recruitment of NOD2 in intestinal epithelial cells is essential for nuclear factor-κB activation in muramyl dipeptide recognition. J Cell Biol (2005) 170(1):21-26.
13. Kufer TA, Kremmer E, Adam AC, Philpott DJ, Sansonetti PJ: The pattern-recognition molecule NOD1 is localized at the plasma membrane at sites of bacterial interaction. Cell Microbiol (2008) 10(2):477-486.
14. Lecine P, Esmiol S, Metais JY, Nicoletti C, Nourry C, McDonald C, Nunez G, Hugot JP, Borg JP, Ollendorff V: The NOD2-Rick complex signals from the plasma membrane. J Biol Chem (2007) 282(20):15197-15207.
15. Moore CB, Bergstralh DT, Duncan JA, Lei Y, Morrison TE, Zimmermann AG, Accavitti-Loper MA, Madden VJ, Sun L, Ye Z, Lich JD et al: NLRX1 is a regulator of mitochondrial antiviral immunity. Nature (2008) 451(7178):573-577.
16. Arnoult D, Soares F, Tattoli I, Castanier C, Philpott DJ, Girardin SE: An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix. J Cell Sci (2009) 122(Pt 17):3161-3168.
17. Martinon F, Burns K, Tschopp J: The inflammasome: A molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol Cell (2002) 10(2): 417-426.
18. Pop C, Timmer J, Sperandio S, Salvesen GS: The apoptosome activates caspase-9 by dimerization. Mol Cell (2006) 22(2): 269-275.
19. Shao W, Yeretssian G, Doiron K, Hussain SN, Saleh M: The caspase-1 digestome identifies the glycolysis pathway as a target during infection and septic shock. J Biol Chem (2007) 282(50):36321-36329.
20. Faustin B, Lartigue L, Bruey JM, Luciano F, Sergienko E, Bailly-Maitre B, Volkmann N, Hanein D, Rouiller I, Reed JC: Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol Cell (2007) 25(5): 713-724.
21. Hlaing T, Guo RF, Dilley KA, Loussia JM, Morrish TA, Shi MM, Vincenz C, Ward PA: Molecular cloning and characterization of DEFCAP-L and -S, two isoforms of a novel member of the mammalian Ced-4 family of apoptosis proteins. J Biol Chem (2001) 276(12):9230-9238.
22. Boyden ED, Dietrich WF: NALP1B controls mouse macrophage susceptibility to anthrax lethal toxin. Nat Genet (2006) 38(2):240-244.
23. Jin Y, Mailloux CM, Gowan K, Riccardi SL, LaBerge G, Bennett DC, Fain PR, Spritz RA: NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med (2007) 356(12):1216-1225.
24. Jin C, Flavell RA: Molecular mechanism of NLRP3 inflammasome activation. J Clin Immunol (2010) 30(5):628-631.
25. Kanneganti TD, Lamkanfi M, Kim YG, Chen G, Park JH, Franchi L, Vandenabeele P, Nunez G: Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of toll-like receptor signaling. Immunity (2007) 26(4):433-443.
26. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, Latz E: Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol (2008) 9(8):847-856.
27. Petrilli V, Dostert C, Muruve DA, Tschopp J: The inflammasome: A danger sensing complex triggering innate immunity. Curr Opin Immunol (2007) 19(6):615-622.
28. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J: Thioredoxininteracting protein links oxidative stress to inflammasome activation. Nat Immunol (2010) 11(2):136-140.
29. Miao EA, Alpuche-Aranda CM, Dors M, Clark AE, Bader MW, Miller SI, Aderem A: Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via IPAF. Nat Immunol (2006) 7(6):569-575.
30. Miao EA, Mao DP, Yudkovsky N, Bonneau R, Lorang CG, Warren SE, Leaf IA, Aderem A: Innate immune detection of the type III secretion apparatus through the NLRC4 inflammasome. Proc Natl Acad Sci USA (2010) 107(7):3076-3080.
31. Lightfield KL, Persson J, Brubaker SW, Witte CE, von Moltke J, Dunipace EA, Henry T, Sun YH, Cado D, Dietrich WF, Monack DM et al: Critical function for NAIP5 in inflammasome activation by a conserved carboxy-terminal domain of flagellin. Nat Immunol (2008) 9(10):1171-1178.
32. Diez E, Lee SH, Gauthier S, Yaraghi Z, Tremblay M, Vidal S, Gros P: Birc1e is the gene within the LGN1 locus associated with resistance to legionella pneumophila. Nat Genet (2003) 33(1):55-60.
33. Fortier A, Doiron K, Saleh M, Grinstein S, Gros P: Restriction of legionella pneumophila replication in macrophages requires concerted action of the transcriptional regulators IRF1 and irf8 and NOD-like receptors naip5 and NLRC4. Infect Immun (2009) 77(11):4794-4805.
34. Labbe K, Miu J, Yeretssian G, Serghides L, Tam M, Finney CA, Erdman LK, Goulet ML, Kain KC, Stevenson MM, Saleh M: Caspase-12 dampens the immune response to malaria independently of the inflammasome by targeting nf-κB signaling. J Immunol (2010):doi:10.4049/jimmunol.1002517.
35. Reimer T, Shaw MH, Franchi L, Coban C, Ishii KJ, Akira S, Horii T, Rodriguez A, Nunez G: Experimental cerebral malaria progresses independently of the NLRP3 inflammasome. Eur J Immunol (2010) 40(3):764-769.
36. Kinoshita T, Wang Y, Hasegawa M, Imamura R, Suda T: Pypaf3, a pyrin-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin-1β secretion. J Biol Chem (2005) 280(23):21720-21725.
37. Williams KL, Lich JD, Duncan JA, Reed W, Rallabhandi P, Moore C, Kurtz S, Coffield VM, Accavitti-Loper MA, Su L, Vogel SN et al: The caterpiller protein monarch-1 is an antagonist of toll-like receptor-, tumor necrosis factor α-, and mycobacterium tuberculosis-induced pro-inflammatory signals. J Biol Chem (2005) 280(48):39914-39924.
38. Tattoli I, Carneiro LA, Jehanno M, Magalhaes JG, Shu Y, Philpott DJ, Arnoult D, Girardin SE: NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-κB and JNK pathways by inducing reactive oxygen species production. EMBO Rep (2008) 9(3):293-300.
39. Girardin SE, Boneca IG, Viala J, Chamaillard M, Labigne A, Thomas G, Philpott DJ, Sansonetti PJ: NOD2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem (2003) 278(11):8869-8872.
40. Inohara N, Koseki T, del Peso L, Hu Y, Yee C, Chen S, Carrio R, Merino J, Liu D, Ni J, Núñez G: NOD1, an APAF-1-like activator of caspase-9 and nuclear factor-κB. J Biol Chem (1999) 274(21):14560-14567.
41. Bertrand MJ, Doiron K, Labbé K, Korneluk RG, Barker PA, Saleh M: Cellular inhibitors of apoptosis cIAP1 and cIAP2 are required for innate immunity signaling by the pattern recognition receptors NOD1 and NOD2. Immunity (2009) 30(6):789-801.
42. Perkins ND: Integrating cell-signalling pathways with nf-κb and ikk function. Nat Rev Mol Cell Biol (2007) 8(1):49-62.
43. Hsu LC, Ali SR, McGillivray S, Tseng PH, Mariathasan S, Humke EW, Eckmann L, Powell JJ, Nizet V, Dixit VM, Karin M: A NOD2-NALP1 complex mediates caspase-1-dependent IL-1β secretion in response to bacillus anthracis infection and muramyl dipeptide. Proc Natl Acad Sci USA (2008) 105(22):7803-7808.
44. LeBlanc PM, Yeretssian G, Rutherford N, Doiron K, Nadiri A, Zhu L, Green DR, Gruenheid S, Saleh M: Caspase-12 modulates NOD signaling and regulates antimicrobial peptide production and mucosal immunity Cell Host Microbe (2008) 3(3):146-157.
45. Mayor A, Martinon F, De Smedt T, Petrilli V, Tschopp J: A crucial function of sgt1 and hsp90 in inflammasome activity links mammalian and plant innate immune responses. Nat Immunol (2007) 8(5):497-503.
46. Rosenstiel P, Huse K, Till A, Hampe J, Hellmig S, Sina C, Billmann S, von Kampen O, Waetzig GH, Platzer M, Seegert D et al: A short isoform of NOD2/CARD15, NOD2-s, is an endogenous inhibitor of NOD2/receptor-interacting protein kinase 2-induced signaling pathways. Proc Natl Acad Sci USA (2006) 103(9):3280-3285.
47. Cui J, Zhu L, Xia X, Wang HY, Legras X, Hong J, Ji J, Shen P, Zheng S, Chen ZJ, Wang RF: NLRC5 negatively regulates the NF-κB and type I interferon signaling pathways. Cell (2010) 141(3):483-496.
48. Bouchier-Hayes L, Conroy H, Egan H, Adrain C, Creagh EM, MacFarlane M, Martin SJ: Cardinal, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-κB activation pathways. J Biol Chem (2001) 276(47): 44069-44077.
49. Greten FR, Arkan MC, Bollrath J, Hsu LC, Goode J, Miething C, Goktuna SI, Neuenhahn M, Fierer J, Paxian S, Van Rooijen N et al: NF-κB is a negative regulator of IL-1β secretion as revealed by genetic and pharmacological inhibition of ikkβ. Cell (2007) 130(5):918-931.
50. Guarda G, Dostert C, Staehli F, Cabalzar K, Castillo R, Tardivel A, Schneider P, Tschopp J: T cells dampen innate immune responses through inhibition of NLRP1 and NLRP3 inflammasomes. Nature (2009) 460(7252):269-273.
51. Faustin B, Chen Y, Zhai D, Le Negrate G, Lartigue L, Satterthwait A, Reed JC: Mechanism of Bcl-2 andBcl-xL inhibition of NLRP1 inflammasome: Loop domain-dependent suppression of ATP binding and oligomerization. Proc Natl Acad Sci USA (2009) 106(10):3935-3940.
52. Humke EW, Shriver SK, Starovasnik MA, Fairbrother WJ, Dixit VM: Iceberg: A novel inhibitor of interleukin-1β generation. Cell (2000) 103(1):99-111.
53. Druilhe A, Srinivasula SM, Razmara M, Ahmad M, Alnemri ES: Regulation of IL-1β generation by pseudo-ICE and iceberg, two dominant negative caspase recruitment domain proteins. Cell Death Differ (2001) 8(6):649-657.
54. Saleh M, Mathison JC, Wolinski MK, Bensinger SJ, Fitzgerald P, Droin N, Ulevitch RJ, Green DR, Nicholson DW: Enhanced bacterial clearance and sepsis resistance in caspase-12- deficient mice. Nature (2006) 440(7087):1064-1068.
55. Saleh M, Vaillancourt JP, Graham RK, Huyck M, Srinivasula SM, Alnemri ES, Steinberg MH, Nolan V, Baldwin CT, Hotchkiss RS, Buchman TG et al: Differential modulation of endotoxin responsiveness by human caspase-12 polymorphisms. Nature (2004) 429(6987):75-79.
56. Yeretssian G, Doiron K, Shao W, Leavitt BR, Hayden MR, Nicholson DW, Saleh M: Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection. Proc Natl Acad Sci USA (2009) 106(22):9016-9020.
57. Stehlik C, Krajewska M, Welsh K, Krajewski S, Godzik A, Reed JC: The paad/pyrin-only protein pop1/asc2 is a modulator of asc-mediated nuclear-factor-κ B and pro-caspase-1 regulation. Biochem J (2003) 373(Pt 1):101-113.
58. Dorfleutner A, Bryan NB, Talbott SJ, Funya KN, Rellick SL, Reed JC, Shi X, Rojanasakul Y, Flynn DC, Stehlik C: Cellular pyrin domain-only protein 2 is a candidate regulator of inflammasome activation. Infect Immun (2007) 75(3): 1484-1492.
59. Brodsky IE, Monack D: Nlr-mediated control of inflammasome assembly in the host response against bacterial pathogens. Semin Immunol (2009) 21(4):199-207.
60. Warren SE, Mao DP, Rodriguez AE, Miao EA, Aderem A: Multiple NOD-like receptors activate caspase 1 during Listeria monocytogenes infection. J Immunol (2008) 180(11):7558-7564.
61. Broz P, Newton K, Lamkanfi M, Mariathasan S, Dixit VM, Monack DM: Redundant roles for inflammasome receptors NLRP3 and NLRC4 in host defense against Salmonella. J Exp Med (2010) 207(8):1745-1755.
62. Poeck H, Bscheider M, Gross O, Finger K, Roth S, Rebsamen M, Hannesschlager N, Schlee M, Rothenfusser S, Barchet W, Kato H et al: Recognition of RNA virus by Rig-I results in activation of CARD9 and inflammasome signaling for interleukin 1 β production. Nat Immunol (2010) 11(1):63-69.
63. Allen IC, Scull MA, Moore CB, Holl EK, McElvania-TeKippe E, Taxman DJ, Guthrie EH, Pickles RJ, Ting JP: The NLRP3 inflammasome mediates in vivo innate immunity to influenza A virus through recognition of viral RNA. Immunity (2009) 30(4):556-565.
64. Thomas PG, Dash P, Aldridge JR Jr, Ellebedy AH, Reynolds C, Funk AJ, Martin WJ, Lamkanfi M, Webby RJ, Boyd KL, Doherty PC et al: The intracellular sensor NLRP3 mediates key innate and healing responses to influenza a virus via the regulation of caspase-1. Immunity (2009) 30(4):566-575.
65. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A: Inflammasome recognition of influenza virus is essential for adaptive immune responses. J Exp Med (2009) 206(1): 79-87.
66. Joly S, Ma N, Sadler JJ, Soll DR, Cassel SL, Sutterwala FS: Cutting edge: Candida albicans hyphae formation triggers activation of the NLRP3 inflammasome. J Immunol (2009) 183(6):3578-3581.
67. Clarke TB, Davis KM, Lysenko ES, Zhou AY, Yu Y, Weiser JN: Recognition of peptidoglycan from the microbiota by NOD1 enhances systemic innate immunity. Nature Med (2010) 16(2):228-231.
68. Fritz JH, Le Bourhis L, Sellge G, Magalhaes JG, Fsihi H, Kufer TA, Collins C, Viala J, Ferrero RL, Girardin SE, Philpott DJ: NOD1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity (2007) 26(4):445-459.
69. Ghiringhelli F, Apetoh L, Tesniere A, Aymeric L, Ma Y, Ortiz C, Vermaelen K, Panaretakis T, Mignot G, Ullrich E, Perfettini JL et al: Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors. Nature Med (2009) 15(10):1170-1178.
70. Franchi L, Nunez G: The nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1β secretion but dispensable for adjuvant activity. Eur J Immunol (2008) 38(8):2085-2089.
71. McKee AS, Munks MW, MacLeod MK, Fleenor CJ, Van Rooijen N, Kappler JW, Marrack P: Alum induces innate immune responses through macrophage and mast cell sensors, but these sensors are not required for alum to act as an adjuvant for specific immunity. J Immunol (2009) 183(7): 4403-4414.
72. Eisenbarth SC, Colegio OR, O'Connor W, Sutterwala FS, Flavell RA: Crucial role for the NALP3 inflammasome in the immunostimulatory properties of aluminium adjuvants. Nature (2008) 453(7198):1122-1126.
73. Kool M, Petrilli V, De Smedt T, Rolaz A, Hammad H, van Nimwegen M, Bergen IM, Castillo R, Lambrecht BN, Tschopp J: Cutting edge: Alum adjuvant stimulates inflammatory dendritic cells through activation of the NALP3 inflammasome. J Immunol (2008) 181(6):3755-3759.
74. Li H, Willingham SB, Ting JP, Re F: Cutting edge: Inflammasome activation by alum and alum's adjuvant effect are mediated by NLRP3. J Immunol (2008) 181(1):17-21.
75. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, Almer S, Tysk C, O'Morain CA, Gassull M, Binder V et al: Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 411(6837):599-603.
76. Villani AC, Lemire M, Fortin G, Louis E, Silverberg MS, Collette C, Baba N, Libioulle C, Belaiche J, Bitton A, Gaudet D et al: Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat Genet (2009) 41(1):71-76.
77. Zaki MH, Boyd KL, Vogel P, Kastan MB, Lamkanfi M, Kanneganti TD: The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity (2010) 32(3):379-391
78. Allen IC, TeKippe EM, Woodford RM, Uronis JM, Holl EK, Rogers AB, Herfarth HH, Jobin C, Ting JP: The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med (2010) 207(5):1045-1056.
79. Salcedo R, Worschech A, Cardone M, Jones Y, Gyulai Z, Dai R-M, Wang E, Ma W, Haines D, O'hUigin C, Marincola FM et al: MyD88-mediated signaling prevents development of adenocarcinomas of the colon: Role of interleukin 18. J Exp Med (2010) 207(8):1625-1636.
80. Bauer C, Duewell P, Mayer C, Lehr HA, Fitzgerald KA, Dauer M, Tschopp J, Endres S, Latz E, Schnurr M: Colitis induced in mice with dextran sulfate sodium (DSS) is mediated by the NLRP3 inflammasome. Gut (2010) 59(9):1192-1199.
81. Feldmeyer L, Keller M, Niklaus G, Hohl D, Werner S, Beer HD: The inflammasome mediates UVB-induced activation and secretion of interleukin-1β by keratinocytes. Curr Biol (2007) 17(13):1140-1145.
82. Hoffman HM, Wanderer AA: Inflammasome and IL-1β-mediated disorders. Curr Allergy Asthma Rep (2010) 10(4):229-235.
83. Brydges SD, Mueller JL, McGeough MD, Pena CA, Misaghi A, Gandhi C, Putnam CD, Boyle DL, Firestein GS, Horner AA, Soroosh P et al: Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity. Immunity (2009) 30(6):875-887.
84. Meng G, Zhang F, Fuss I, Kitani A, Strober W: A mutation in the NLRP3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses. Immunity (2009) 30(6):860-874.
85. Martinon F, Petrilli V, Mayor A, Tardivel A, Tschopp J: Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature (2006) 440(7081):237-241.
86. Dostert C, Petrilli V, Van Bruggen R, Steele C, Mossman BT, Tschopp J: Innate immune activation through NALP3 inflammasome sensing of asbestos and silica. Science (2008) 320(5876):674-677.
87. Imaeda AB, Watanabe A, Sohail MA, Mahmood S, Mohamadnejad M, Sutterwala FS, Flavell RA, Mehal WZ: Acetaminopheninduced hepatotoxicity in mice is dependent on TLR9 and the NALP3 inflammasome. J Clin Invest (2009) 119(2):305-314.
88. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, Espevik T et al: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature (2010) 464(7293):1357-1361.
89. Ona VO, Li M, Vonsattel JP, Andrews LJ, Khan SQ, Chung WM, Frey AS, Menon AS, Li XJ, Stieg PE, Yuan J et al: Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease. Nature (1999) 399(6733):263-267.
90. Halle A, Hornung V, Petzold GC, Stewart CR, Monks BG, Reinheckel T, Fitzgerald KA, Latz E, Moore KJ, Golenbock DT: The NALP3 inflammasome is involved in the innate immune response to amyloid-β. Nat Immunol (2008) 9(8): 857-865.
91. Watanabe H, Gaide O, Petrilli V, Martinon F, Contassot E, Roques S, Kummer JA, Tschopp J, French LE: Activation of the IL-1β-processing inflammasome is involved in contact hypersensitivity. J Invest Dermatol (2007) 127(8):1956-1963.
92. Sutterwala FS, Ogura Y, Szczepanik M, Lara-Tejero M, Lichtenberger GS, Grant EP, Bertin J, Coyle AJ, Galan JE, Askenase PW, Flavell RA: Critical role for NALP3/cias1/cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity (2006) 24(3):317-327.
93. Dinarello CA: The role of the interleukin-1-receptor antagonist in blocking inflammation mediated by interleukin-1. N Eng J Med (2000) 343(10):732-734.
94. Economides AN, Carpenter LR, Rudge JS, Wong V, Koehler-Stec EM, Hartnett C, Pyles EA, Xu X, Daly TJ, Young MR, Fandl JP et al: Cytokine traps: Multi-component, high-affinity blockers of cytokine action. Nat Med (2003) 9(1):47-52.
95. Goldbach-Mansky R, Shroff SD, Wilson M, Snyder C, Plehn S, Barham B, Pham TH, Pucino F, Wesley RA, Papadopoulos JH, Weinstein SP et al: A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome. Arthritis Rheum (2008) 58(8): 2432-2442.
96. Toker O, Hashkes PJ: Critical appraisal of canakinumab in the treatment of adults and children with cryopyrinassociated periodic syndrome (caps). Biologics (2010) 4: 131-138.
97. Ioannis M, Panagiotis S, Konstantinos R: Targeting IL-1β in disease; the expanding role of NLRP3 inflammasome. Eur J Intern Med (2010) 21(3):157-163.
98. Lamkanfi M, Sarkar A, Vande Walle L, Vitari AC, Amer AO, Wewers MD, Tracey KJ, Kanneganti TD, Dixit VM: Inflammasomedependent release of the alarmin hmgb1 in endotoxemia. J Immunol (2010) 185(7):4385-4392.
99. Carta S, Castellani P, Delfino L, Tassi S, Vene R, Rubartelli A: Damps and inflammatory processes: The role of redox in the different outcomes. J Leukoc Biol (2009) 86(3):549-555.
100. van de Veerdonk FL, Smeekens SP, Joosten LA, Kullberg BJ, Dinarello CA, van der Meer JW, Netea MG: Reactive oxygen species-independent activation of the IL-1β inflammasome in cells from patients with chronic granulomatous disease. Proc Natl Acad Sci USA (2010) 107(7):3030-3033.
101. Dostert C, Guarda G, Romero JF, Menu P, Gross O, Tardivel A, Suva ML, Stehle JC, Kopf M, Stamenkovic I, Corradin G et al: Malarial hemozoin is a NALP3 inflammasome activating danger signal. PLoS One (2009) 4(8):e6510.
102. Griffith JW, Sun T, McIntosh MT, Bucala R: Pure hemozoin is inflammatory in vivo and activates the NALP3 inflammasome via release of uric acid. J Immunol (2009) 183(8):5208-5220.
103. Shio MT, Eisenbarth SC, Savaria M, Vinet AF, Bellemare MJ, Harder KW, Sutterwala FS, Bohle DS, Descoteaux A, Flavell RA, Olivier M: Malarial hemozoin activates the NLRP3 inflammasome through Lyn and Syk kinases. PLoS Pathog (2009) 5(8):e1000559.
104. Gross O, Poeck H, Bscheider M, Dostert C, Hannesschlager N, Endres S, Hartmann G, Tardivel A, Schweighoffer E, Tybulewicz V, Mocsai A et al: Syk kinase signalling couples to the NLRP3 inflammasome for anti-fungal host defence. Nature (2009) 459(7245):433-436.
105. Hise AG, Tomalka J, Ganesan S, Patel K, Hall BA, Brown GD, Fitzgerald KA: An essential role for the NLRP3 inflammasome in host defense against the human fungal pathogen Candida albicans. Cell Host Microbe (2009) 5(5): 487-497.
106. Murdoch S, Djuric U, Mazhar B, Seoud M, Khan R, Kuick R, Bagga R, Kircheisen R, Ao A, Ratti B, Hanash S et al: Mutations in NALP7 cause recurrent hydatidiform moles and reproductive wastage in humans. Nat Genet (2006) 38(3): 300-302.
107. Jeru I, Duquesnoy P, Fernandes-Alnemri T, Cochet E, Yu JW, Lackmy-Port-Lis M, Grimprel E, Landman-Parker J, Hentgen V, Marlin S, McElreavey K et al: Mutations in NALP12 cause hereditary periodic fever syndromes. Proc Natl Acad Sci USA (2008) 105(5):1614-1619.